|
Market Closed -
Euronext Paris
11:55:00 2026-09-18 am EDT
|
5-day change | 1st Jan Change | ||
| 21.10 EUR | -16.27% |
|
-18.85% | -30.36% |
| Sep. 17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Apr. 22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 366M 420M 346M 314M 589M 40.31B 591M 4.14B 1.6B 20.5B 1.58B 1.54B 65.95B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 318M 365M 301M 273M 512M 35.05B 514M 3.6B 1.39B 17.82B 1.37B 1.34B 57.33B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
CBOE
| BOIp | Real-time | |
|
Börse Stuttgart
| BON | Delayed | |
|
Boerse Muenchen
| BON | Real-time | |
|
OTC Markets
| BOIRF | Delayed | |
|
Deutsche Boerse AG
| BON | Delayed | |
|
CBOE
| 0DTF | Real-time |
| 1 day | -16.27% | ||
| 1 week | -18.85% | ||
| Current month | -17.25% | ||
| 1 month | -18.85% | ||
| 3 months | -23.83% | ||
| 6 months | -18.85% | ||
| Current year | -30.36% |
| 1 week | 20.5 |  | 25.6 |
| 1 month | 20.5 | | 26.7 |
| Current year | 20.5 | | 30.95 |
| 1 year | 20.5 | | 32.25 |
| 3 years | 20.5 | | 56.5 |
| 5 years | 20.5 | | 56.5 |
| 10 years | 20.5 | | 92.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.27% | -18.85% | -27.74% | -60.85% | 420M | |
| -0.66% | +1.29% | -12.71% | -5.50% | 13.59B | |
| 0.00% | -0.77% | -33.26% | -56.76% | 4.75B | |
| -0.68% | -1.27% | -5.37% | -7.25% | 4.31B | |
| +0.53% | +0.07% | -7.65% | -34.57% | 3.79B | |
| +0.16% | +1.57% | -1.06% | -4.29% | 3.46B | |
| +1.38% | -0.06% | -21.64% | +0.76% | 3.44B | |
| -0.57% | -1.14% | -11.32% | -0.50% | 3.09B | |
| -0.62% | +0.48% | -22.17% | -18.55% | 2.25B | |
| +0.52% | +0.16% | -27.89% | -23.13% | 1.64B | |
| Average | -1.62% | -2.63% | -17.08% | -21.07% | 4.07B | |
| Weighted average by Cap. | -0.34% | -0.78% | -14.80% | -15.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 559M 460M 418M 783M 53.65B 787M 5.51B 2.13B 27.28B 2.1B 2.05B 87.77B | 501M 575M 473M 430M 805M 55.14B 808M 5.67B 2.19B 28.03B 2.16B 2.11B 90.21B |
| Net income | 11.34M 13M 10.7M 9.72M 18.21M 1.25B 18.29M 128M 49.48M 634M 48.83M 47.75M 2.04B | 32.64M 37.43M 30.82M 27.99M 52.44M 3.59B 52.66M 369M 142M 1.83B 141M 138M 5.88B |
| Net Debt | -49.74M -57.04M -46.96M -42.65M -79.9M -5.47B -80.24M -563M -217M -2.78B -214M -210M -8.95B | -47.86M -54.88M -45.19M -41.03M -76.88M -5.27B -77.2M -541M -209M -2.68B -206M -202M -8.61B |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | €21.10 | -16.27% | 47,999 |
| 26-09-17 | €25.20 | +0.80% | 1,994 |
| 26-09-16 | €25.00 | 0.00% | 2,598 |
| 26-09-15 | €25.00 | -2.34% | 2,817 |
| 26-09-14 | €25.60 | -1.54% | 1,369 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
